Memphis Pharmaceuticals & Chemical Industries (EGX:MPCI)

Market Cap	1.35B
Revenue (ttm)	1.23B
Net Income (ttm)	376.65M
Shares Out	22.75M
EPS (ttm)	66.96
PE Ratio	0.89
Forward PE	n/a
Dividend	4.00 (6.75%)
Ex-Dividend Date	Nov 13, 2024

Volume	81,896
Average Volume	135,551
Open	60.14
Previous Close	60.14
Day's Range	59.05 - 60.70
52-Week Range	31.00 - 139.99
Beta	0.12
RSI	55.78
Earnings Date	Feb 10, 2025

About EGX:MPCI

Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal ...

• Industry: Pharmaceutical Preparations
• Founded: 1940
• Employees: 144
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: MPCI

Financial Performance

In 2024, EGX:MPCI's revenue was 871.91 million, an increase of 31.34% compared to the previous year's 663.83 million. Earnings were 191.46 million, an increase of 111.70%.